SYN-TECH Chem. & Pharm. Co., Ltd. (TPEX:1777)
Taiwan
· Delayed Price · Currency is TWD 71.50
+0.20 (0.28%)
At close: Mar 6, 2026
SYN-TECH Chem. & Pharm. Income Statement
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Revenue | 1,300 | 1,258 | 1,115 | 986.3 | 893.23 | Upgrade
|
| Revenue Growth (YoY) | 3.38% | 12.83% | 13.02% | 10.42% | -9.21% | Upgrade
|
| Cost of Revenue | 849.88 | 770.72 | 705.17 | 618.3 | 601.88 | Upgrade
|
| Gross Profit | 450.36 | 486.94 | 409.52 | 368 | 291.35 | Upgrade
|
| Selling, General & Admin | 91.63 | 93.45 | 89.73 | 89.91 | 86.29 | Upgrade
|
| Research & Development | 38.87 | 42.51 | 37.91 | 39.86 | 36.48 | Upgrade
|
| Operating Expenses | 130.5 | 136.14 | 127.67 | 129.77 | 122.77 | Upgrade
|
| Operating Income | 319.86 | 350.8 | 281.85 | 238.23 | 168.59 | Upgrade
|
| Interest Expense | -1 | -2.14 | -5.74 | -5.92 | -3.39 | Upgrade
|
| Interest & Investment Income | 16.89 | 20.31 | 29.73 | 16.01 | 2.26 | Upgrade
|
| Earnings From Equity Investments | - | - | 0.7 | -11.59 | -0.73 | Upgrade
|
| Currency Exchange Gain (Loss) | - | 42.97 | 2.57 | 89.96 | -18.79 | Upgrade
|
| Other Non Operating Income (Expenses) | -1.83 | 7.35 | 5.42 | 34.99 | 119.22 | Upgrade
|
| EBT Excluding Unusual Items | 333.92 | 419.29 | 314.53 | 361.68 | 267.15 | Upgrade
|
| Gain (Loss) on Sale of Investments | - | -0.78 | - | -6.15 | - | Upgrade
|
| Gain (Loss) on Sale of Assets | - | -5.48 | -0.77 | -0.3 | -0.73 | Upgrade
|
| Other Unusual Items | - | - | - | - | -237.39 | Upgrade
|
| Pretax Income | 333.92 | 488.24 | 313.77 | 355.24 | 200.23 | Upgrade
|
| Income Tax Expense | 72.31 | 94.95 | 62.76 | 59.95 | 23.07 | Upgrade
|
| Net Income | 261.61 | 393.28 | 251.01 | 295.29 | 177.16 | Upgrade
|
| Net Income to Common | 261.61 | 393.28 | 251.01 | 295.29 | 177.16 | Upgrade
|
| Net Income Growth | -33.48% | 56.68% | -14.99% | 66.68% | -5.13% | Upgrade
|
| Shares Outstanding (Basic) | 45 | 45 | 45 | 45 | 35 | Upgrade
|
| Shares Outstanding (Diluted) | 45 | 45 | 45 | 45 | 35 | Upgrade
|
| Shares Change (YoY) | 0.05% | 0.03% | 0.05% | 26.57% | 17.18% | Upgrade
|
| EPS (Basic) | 5.87 | 8.82 | 5.63 | 6.62 | 5.03 | Upgrade
|
| EPS (Diluted) | 5.85 | 8.80 | 5.62 | 6.61 | 5.02 | Upgrade
|
| EPS Growth | -33.52% | 56.58% | -14.98% | 31.67% | -19.03% | Upgrade
|
| Free Cash Flow | 501.19 | 408.92 | -175.05 | -38.59 | 24.93 | Upgrade
|
| Free Cash Flow Per Share | 11.21 | 9.15 | -3.92 | -0.86 | 0.71 | Upgrade
|
| Dividend Per Share | - | 5.300 | 3.500 | 3.000 | 2.150 | Upgrade
|
| Dividend Growth | - | 51.43% | 16.67% | 39.53% | -46.25% | Upgrade
|
| Gross Margin | 34.64% | 38.72% | 36.74% | 37.31% | 32.62% | Upgrade
|
| Operating Margin | 24.60% | 27.89% | 25.29% | 24.15% | 18.87% | Upgrade
|
| Profit Margin | 20.12% | 31.27% | 22.52% | 29.94% | 19.83% | Upgrade
|
| Free Cash Flow Margin | 38.55% | 32.51% | -15.70% | -3.91% | 2.79% | Upgrade
|
| EBITDA | 467 | 491.55 | 390.36 | 316.24 | 237.6 | Upgrade
|
| EBITDA Margin | 35.92% | 39.09% | 35.02% | 32.06% | 26.60% | Upgrade
|
| D&A For EBITDA | 147.14 | 140.75 | 108.51 | 78.01 | 69.01 | Upgrade
|
| EBIT | 319.86 | 350.8 | 281.85 | 238.23 | 168.59 | Upgrade
|
| EBIT Margin | 24.60% | 27.89% | 25.29% | 24.15% | 18.87% | Upgrade
|
| Effective Tax Rate | 21.65% | 19.45% | 20.00% | 16.88% | 11.52% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.